B. Riley Predicts Aspen Aerogels FY2024 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at B. Riley issued their FY2024 earnings estimates for shares of Aspen Aerogels in a research report issued on Monday, January 6th. B. Riley analyst R. Pfingst anticipates that the construction company will post earnings of $0.16 per share for the year. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. B. Riley also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at $0.09 EPS, Q2 2025 earnings at $0.12 EPS, Q3 2025 earnings at $0.16 EPS, Q4 2025 earnings at $0.18 EPS, FY2025 earnings at $0.54 EPS, FY2026 earnings at $0.87 EPS and FY2027 earnings at $1.33 EPS.

Several other equities analysts have also weighed in on ASPN. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, November 13th. HC Wainwright reissued a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Roth Mkm decreased their target price on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Barclays dropped their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 12th. Finally, Piper Sandler lowered their target price on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. One analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $30.00.

Aspen Aerogels Price Performance

ASPN opened at $13.18 on Thursday. The stock has a fifty day moving average price of $14.05 and a 200 day moving average price of $20.73. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a 1 year low of $10.75 and a 1 year high of $33.15. The stock has a market cap of $1.08 billion, a price-to-earnings ratio of 1,319.32 and a beta of 2.14.

Institutional Trading of Aspen Aerogels

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC acquired a new stake in shares of Aspen Aerogels during the third quarter worth $10,126,000. Franklin Resources Inc. increased its stake in shares of Aspen Aerogels by 5.3% in the 3rd quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after acquiring an additional 1,483 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in shares of Aspen Aerogels in the 3rd quarter valued at approximately $498,000. Geode Capital Management LLC boosted its stake in Aspen Aerogels by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after acquiring an additional 75,024 shares during the last quarter. Finally, Barclays PLC grew its holdings in Aspen Aerogels by 333.8% during the third quarter. Barclays PLC now owns 92,302 shares of the construction company’s stock valued at $2,557,000 after purchasing an additional 71,024 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.